Safety and efficacy of cutting balloon angioplasty: the Mayo Clinic experience. J Invasive Cardiol 2002 Dec;14(12):720-4
Date
11/28/2002Pubmed ID
12454332Scopus ID
2-s2.0-0036916827 (requires institutional sign-in at Scopus site) 15 CitationsAbstract
UNLABELLED: A number of evolving clinical indications for cutting balloon angioplasty (CBA) have been described in the clinical literature, including angioplasty-resistant stenoses, in-stent restenosis, ostial lesions and small vessel disease.
METHODS: We analyzed the Mayo Clinic PTCA registry and report procedural and in-hospital clinical outcomes in 100 patients (103 procedures, 114 lesions) undergoing CBA.
RESULTS: CBA was successfully completed in 109 lesions (96%). The majority of lesions (73%) required additional treatment with either balloon angioplasty (39%) or stent implantation (34%). Severe intimal dissection resulting in at least 50% luminal obstruction occurred in 13 lesions (11%). A single incident of branch occlusion was documented, resulting in ST elevation myocardial infarction. There were no incidents of vessel perforation, urgent percutaneous or surgical target vessel revascularization, or in-hospital death.
CONCLUSION: CBA is feasible and safe, with a low incidence of procedural complications and in-hospital adverse cardiac events when used primarily for in-stent restenosis.
Author List
Orford JL, Fasseas P, Denktas AE, Hammes L, Garratt KN, Berger PB, Holmes DR, Barsness GWAuthor
Panayotis Fasseas MD Associate Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Academic Medical CentersAged
Angina, Unstable
Angioplasty, Balloon
Coronary Angiography
Equipment Design
Equipment Safety
Female
Follow-Up Studies
Humans
Male
Middle Aged
Minnesota
Myocardial Infarction
Prognosis
Registries
Retrospective Studies
Risk Assessment
Severity of Illness Index
Stents
Treatment Outcome
